Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6–K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE13a-16 OR15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
February 3, 2020
Commission File Number001-39059
AVITA MEDICAL LIMITED
(Name of Registrant)
Level 7, 330 Collins Street
Melbourne VIC 3000 Australia
Tel: +61 (0) 3 8689 9997
Fax: +61 (0) 8 9474 7742
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under coverForm 20-F orForm 40-F.
Form20-F ☒ Form40-F ☐
Indicate by check mark if the registrant is submitting the Form6-K in paper as permitted by RegulationS-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form6-K in paper as permitted by RegulationS-T Rule 101(b)(7): ☐
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule12g3-2(b) under the Securities Exchange Act of 1934. Yes ☐ No ☒
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule12g3-2(b): 82- .
Table of Contents
AVITA MEDICAL LIMITED
Form6-K
Page | ||||
Explanatory Note | Page 2 | |||
Signatures | Page 3 | |||
Press Release: AVITA Medical Reports Second Quarter Fiscal 2020 Financial Results and Company Update | Exhibit 99.1 |
Avita Medical Limited (the “Company”) published an announcement (the “Public Notice”) to the Australian Securities Exchange on January 31, 2020 titled “Avita Medical Reports Second Quarter Fiscal 2020 Financial Results and Company Update”. A copy of the Public Notice is attached as an exhibit to this report on Form6-K.
This report on Form6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
2
Table of Contents
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Avita Medical Limited | ||
By: | /s/ Michael Perry | |
Name: | Michael Perry | |
Title: | Chief Executive Officer |
Date: February 3, 2020
3